Global Human Organoids Market

Human Organoids Comprehensive Study by Type (Brain Organoids, Kidney Organoids, Lung Organoids, Intestine Organoids, Liver Organoids, Others), Application (Study of Infection Biology, Genetic Engineering, Pathology, Drug Designing, Therapeutic Tools, Others), End User (Clinical Research Organization, Pharmaceutical Companies, Biotech Companies), Components (Reagents, Platform, Media) Players and Region - Global Market Outlook to 2028

Human Organoids Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Human Organoids
Human Organoids are small or mini human three-dimensional tissues made up of stem cells. These tissue cultures can be generated into any human tissue. Certain Companies and Scientists have been successful in generating miniature organs composed of many cells which are made up of stem cells in the perfect environment. The size of miniature organs and tissues may vary. Organoids also reduce the time cycle of new drug discovery. They allow researchers to design targeted drugs for their performance according to specific individual needs. To date, Scientists and Researchers have been successful in developing Brain, Liver, Stomach, Kidney, and Retina as major organoids along with other organoids. Although establishing global standards for human organoids and practices remains a major challenge. Setting a perfect environment for further advancement also remains a major constraint for the growth of the market of human organoids. Currently, North America is the most dominant major market of human organoids, followed by Europe and Asia Pacific respectively.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Sigma-Aldrich, Inc. (United States), Thermo Fisher Scientific (United States), TEMCELL Technologies Inc. (Canada), Organovo (United States), BioIVT (United States), 3D Biomatrix, Inc. (United States), Biopredic International (France), Kaly-Cell (France), InSphero AG (Switzerland) and 3D Biotek LLC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Cyfuse Biomedical (Japan), Promethera Biosciences (Belgium) and Pandorum Technologies (India).

Segmentation Overview
AMA Research has segmented the market of Global Human Organoids market by Type (Brain Organoids, Kidney Organoids, Lung Organoids, Intestine Organoids, Liver Organoids and Others), Application (Study of Infection Biology, Genetic Engineering, Pathology, Drug Designing, Therapeutic Tools and Others) and Region.



On the basis of geography, the market of Human Organoids has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User , the sub-segment i.e. Clinical Research Organization will boost the Human Organoids market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Components , the sub-segment i.e. Reagents will boost the Human Organoids market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Neural Organoid or Brain Organoid are Widely Produced and Studied

Market Growth Drivers:
Increasing Investment in Research and Development of New Drugs Development, Growing Prevalence of Infectious Diseases and Rising Popularity Alternatives of Animal Testing Models

Challenges:
The Human Organoids are Still in the Early Stages of Development and Suspicions in Patients while giving consent to his/her Cell Organoid Generation

Restraints:
Lack of Global Standardization of Human Organoids and The Development of Human Organoids is Relatively Expensive

Opportunities:
Possibility of Personalised Drug Solutions and Advancement in Tissue Engineering, Drug Discovery, and Regenerative Medicine is Possible through Human Organoids Development

Market Leaders and their expansionary development strategies
In 2020, Cancer Genetics, Inc., a US-based one of the market leaders in drug discovery and oncology services announced the acquisition of Human Organoids development startup StemoniX, Inc., and the merger of the same with its subsidiary specializing in Organoid development. The acquisition will accelerate Cancer Genetics human induced pluripotent stem cell-derived neural and cardiac organoid development along with saving both time and capital for new drug discovery.
In July 2019, Organovo presented information and data about its company and the production of stem cell-based kidney tissue at the 2019 International Society for Stem Cell Research Annual Meeting in the United States.
Human Organoids and Similar Human Tissue Development are regulated under 21 CFR Parts 1270 and 1271 of The Center for Biologics Evaluation and Research, which is an organization under the US FDA

Key Target Audience
Human Organoids Producers, New Entrants/Investors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Brain Organoids
  • Kidney Organoids
  • Lung Organoids
  • Intestine Organoids
  • Liver Organoids
  • Others
By Application
  • Study of Infection Biology
  • Genetic Engineering
  • Pathology
  • Drug Designing
  • Therapeutic Tools
  • Others
By End User
  • Clinical Research Organization
  • Pharmaceutical Companies
  • Biotech Companies

By Components
  • Reagents
  • Platform
  • Media

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Investment in Research and Development of New Drugs Development
      • 3.2.2. Growing Prevalence of Infectious Diseases
      • 3.2.3. Rising Popularity Alternatives of Animal Testing Models
    • 3.3. Market Challenges
      • 3.3.1. The Human Organoids are Still in the Early Stages of Development
      • 3.3.2. Suspicions in Patients while giving consent to his/her Cell Organoid Generation
    • 3.4. Market Trends
      • 3.4.1. Neural Organoid or Brain Organoid are Widely Produced and Studied
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Human Organoids, by Type, Application, End User , Components and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Human Organoids (Value)
      • 5.2.1. Global Human Organoids by: Type (Value)
        • 5.2.1.1. Brain Organoids
        • 5.2.1.2. Kidney Organoids
        • 5.2.1.3. Lung Organoids
        • 5.2.1.4. Intestine Organoids
        • 5.2.1.5. Liver Organoids
        • 5.2.1.6. Others
      • 5.2.2. Global Human Organoids by: Application (Value)
        • 5.2.2.1. Study of Infection Biology
        • 5.2.2.2. Genetic Engineering
        • 5.2.2.3. Pathology
        • 5.2.2.4. Drug Designing
        • 5.2.2.5. Therapeutic Tools
        • 5.2.2.6. Others
      • 5.2.3. Global Human Organoids Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Human Organoids: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sigma-Aldrich, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. TEMCELL Technologies Inc. (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Organovo (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioIVT (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. 3D Biomatrix, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Biopredic International (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Kaly-Cell (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. InSphero AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. 3D Biotek LLC (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Human Organoids Sale, by Type, Application, End User , Components and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Human Organoids (Value)
      • 7.2.1. Global Human Organoids by: Type (Value)
        • 7.2.1.1. Brain Organoids
        • 7.2.1.2. Kidney Organoids
        • 7.2.1.3. Lung Organoids
        • 7.2.1.4. Intestine Organoids
        • 7.2.1.5. Liver Organoids
        • 7.2.1.6. Others
      • 7.2.2. Global Human Organoids by: Application (Value)
        • 7.2.2.1. Study of Infection Biology
        • 7.2.2.2. Genetic Engineering
        • 7.2.2.3. Pathology
        • 7.2.2.4. Drug Designing
        • 7.2.2.5. Therapeutic Tools
        • 7.2.2.6. Others
      • 7.2.3. Global Human Organoids Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Human Organoids: by Type(USD Million)
  • Table 2. Human Organoids Brain Organoids , by Region USD Million (2017-2022)
  • Table 3. Human Organoids Kidney Organoids , by Region USD Million (2017-2022)
  • Table 4. Human Organoids Lung Organoids , by Region USD Million (2017-2022)
  • Table 5. Human Organoids Intestine Organoids , by Region USD Million (2017-2022)
  • Table 6. Human Organoids Liver Organoids , by Region USD Million (2017-2022)
  • Table 7. Human Organoids Others , by Region USD Million (2017-2022)
  • Table 8. Human Organoids: by Application(USD Million)
  • Table 9. Human Organoids Study of Infection Biology , by Region USD Million (2017-2022)
  • Table 10. Human Organoids Genetic Engineering , by Region USD Million (2017-2022)
  • Table 11. Human Organoids Pathology , by Region USD Million (2017-2022)
  • Table 12. Human Organoids Drug Designing , by Region USD Million (2017-2022)
  • Table 13. Human Organoids Therapeutic Tools , by Region USD Million (2017-2022)
  • Table 14. Human Organoids Others , by Region USD Million (2017-2022)
  • Table 15. South America Human Organoids, by Country USD Million (2017-2022)
  • Table 16. South America Human Organoids, by Type USD Million (2017-2022)
  • Table 17. South America Human Organoids, by Application USD Million (2017-2022)
  • Table 18. South America Human Organoids, by End User USD Million (2017-2022)
  • Table 19. South America Human Organoids, by Components USD Million (2017-2022)
  • Table 20. Brazil Human Organoids, by Type USD Million (2017-2022)
  • Table 21. Brazil Human Organoids, by Application USD Million (2017-2022)
  • Table 22. Brazil Human Organoids, by End User USD Million (2017-2022)
  • Table 23. Brazil Human Organoids, by Components USD Million (2017-2022)
  • Table 24. Argentina Human Organoids, by Type USD Million (2017-2022)
  • Table 25. Argentina Human Organoids, by Application USD Million (2017-2022)
  • Table 26. Argentina Human Organoids, by End User USD Million (2017-2022)
  • Table 27. Argentina Human Organoids, by Components USD Million (2017-2022)
  • Table 28. Rest of South America Human Organoids, by Type USD Million (2017-2022)
  • Table 29. Rest of South America Human Organoids, by Application USD Million (2017-2022)
  • Table 30. Rest of South America Human Organoids, by End User USD Million (2017-2022)
  • Table 31. Rest of South America Human Organoids, by Components USD Million (2017-2022)
  • Table 32. Asia Pacific Human Organoids, by Country USD Million (2017-2022)
  • Table 33. Asia Pacific Human Organoids, by Type USD Million (2017-2022)
  • Table 34. Asia Pacific Human Organoids, by Application USD Million (2017-2022)
  • Table 35. Asia Pacific Human Organoids, by End User USD Million (2017-2022)
  • Table 36. Asia Pacific Human Organoids, by Components USD Million (2017-2022)
  • Table 37. China Human Organoids, by Type USD Million (2017-2022)
  • Table 38. China Human Organoids, by Application USD Million (2017-2022)
  • Table 39. China Human Organoids, by End User USD Million (2017-2022)
  • Table 40. China Human Organoids, by Components USD Million (2017-2022)
  • Table 41. Japan Human Organoids, by Type USD Million (2017-2022)
  • Table 42. Japan Human Organoids, by Application USD Million (2017-2022)
  • Table 43. Japan Human Organoids, by End User USD Million (2017-2022)
  • Table 44. Japan Human Organoids, by Components USD Million (2017-2022)
  • Table 45. India Human Organoids, by Type USD Million (2017-2022)
  • Table 46. India Human Organoids, by Application USD Million (2017-2022)
  • Table 47. India Human Organoids, by End User USD Million (2017-2022)
  • Table 48. India Human Organoids, by Components USD Million (2017-2022)
  • Table 49. South Korea Human Organoids, by Type USD Million (2017-2022)
  • Table 50. South Korea Human Organoids, by Application USD Million (2017-2022)
  • Table 51. South Korea Human Organoids, by End User USD Million (2017-2022)
  • Table 52. South Korea Human Organoids, by Components USD Million (2017-2022)
  • Table 53. Taiwan Human Organoids, by Type USD Million (2017-2022)
  • Table 54. Taiwan Human Organoids, by Application USD Million (2017-2022)
  • Table 55. Taiwan Human Organoids, by End User USD Million (2017-2022)
  • Table 56. Taiwan Human Organoids, by Components USD Million (2017-2022)
  • Table 57. Australia Human Organoids, by Type USD Million (2017-2022)
  • Table 58. Australia Human Organoids, by Application USD Million (2017-2022)
  • Table 59. Australia Human Organoids, by End User USD Million (2017-2022)
  • Table 60. Australia Human Organoids, by Components USD Million (2017-2022)
  • Table 61. Rest of Asia-Pacific Human Organoids, by Type USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Human Organoids, by Application USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Human Organoids, by End User USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Human Organoids, by Components USD Million (2017-2022)
  • Table 65. Europe Human Organoids, by Country USD Million (2017-2022)
  • Table 66. Europe Human Organoids, by Type USD Million (2017-2022)
  • Table 67. Europe Human Organoids, by Application USD Million (2017-2022)
  • Table 68. Europe Human Organoids, by End User USD Million (2017-2022)
  • Table 69. Europe Human Organoids, by Components USD Million (2017-2022)
  • Table 70. Germany Human Organoids, by Type USD Million (2017-2022)
  • Table 71. Germany Human Organoids, by Application USD Million (2017-2022)
  • Table 72. Germany Human Organoids, by End User USD Million (2017-2022)
  • Table 73. Germany Human Organoids, by Components USD Million (2017-2022)
  • Table 74. France Human Organoids, by Type USD Million (2017-2022)
  • Table 75. France Human Organoids, by Application USD Million (2017-2022)
  • Table 76. France Human Organoids, by End User USD Million (2017-2022)
  • Table 77. France Human Organoids, by Components USD Million (2017-2022)
  • Table 78. Italy Human Organoids, by Type USD Million (2017-2022)
  • Table 79. Italy Human Organoids, by Application USD Million (2017-2022)
  • Table 80. Italy Human Organoids, by End User USD Million (2017-2022)
  • Table 81. Italy Human Organoids, by Components USD Million (2017-2022)
  • Table 82. United Kingdom Human Organoids, by Type USD Million (2017-2022)
  • Table 83. United Kingdom Human Organoids, by Application USD Million (2017-2022)
  • Table 84. United Kingdom Human Organoids, by End User USD Million (2017-2022)
  • Table 85. United Kingdom Human Organoids, by Components USD Million (2017-2022)
  • Table 86. Netherlands Human Organoids, by Type USD Million (2017-2022)
  • Table 87. Netherlands Human Organoids, by Application USD Million (2017-2022)
  • Table 88. Netherlands Human Organoids, by End User USD Million (2017-2022)
  • Table 89. Netherlands Human Organoids, by Components USD Million (2017-2022)
  • Table 90. Rest of Europe Human Organoids, by Type USD Million (2017-2022)
  • Table 91. Rest of Europe Human Organoids, by Application USD Million (2017-2022)
  • Table 92. Rest of Europe Human Organoids, by End User USD Million (2017-2022)
  • Table 93. Rest of Europe Human Organoids, by Components USD Million (2017-2022)
  • Table 94. MEA Human Organoids, by Country USD Million (2017-2022)
  • Table 95. MEA Human Organoids, by Type USD Million (2017-2022)
  • Table 96. MEA Human Organoids, by Application USD Million (2017-2022)
  • Table 97. MEA Human Organoids, by End User USD Million (2017-2022)
  • Table 98. MEA Human Organoids, by Components USD Million (2017-2022)
  • Table 99. Middle East Human Organoids, by Type USD Million (2017-2022)
  • Table 100. Middle East Human Organoids, by Application USD Million (2017-2022)
  • Table 101. Middle East Human Organoids, by End User USD Million (2017-2022)
  • Table 102. Middle East Human Organoids, by Components USD Million (2017-2022)
  • Table 103. Africa Human Organoids, by Type USD Million (2017-2022)
  • Table 104. Africa Human Organoids, by Application USD Million (2017-2022)
  • Table 105. Africa Human Organoids, by End User USD Million (2017-2022)
  • Table 106. Africa Human Organoids, by Components USD Million (2017-2022)
  • Table 107. North America Human Organoids, by Country USD Million (2017-2022)
  • Table 108. North America Human Organoids, by Type USD Million (2017-2022)
  • Table 109. North America Human Organoids, by Application USD Million (2017-2022)
  • Table 110. North America Human Organoids, by End User USD Million (2017-2022)
  • Table 111. North America Human Organoids, by Components USD Million (2017-2022)
  • Table 112. United States Human Organoids, by Type USD Million (2017-2022)
  • Table 113. United States Human Organoids, by Application USD Million (2017-2022)
  • Table 114. United States Human Organoids, by End User USD Million (2017-2022)
  • Table 115. United States Human Organoids, by Components USD Million (2017-2022)
  • Table 116. Canada Human Organoids, by Type USD Million (2017-2022)
  • Table 117. Canada Human Organoids, by Application USD Million (2017-2022)
  • Table 118. Canada Human Organoids, by End User USD Million (2017-2022)
  • Table 119. Canada Human Organoids, by Components USD Million (2017-2022)
  • Table 120. Mexico Human Organoids, by Type USD Million (2017-2022)
  • Table 121. Mexico Human Organoids, by Application USD Million (2017-2022)
  • Table 122. Mexico Human Organoids, by End User USD Million (2017-2022)
  • Table 123. Mexico Human Organoids, by Components USD Million (2017-2022)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Human Organoids: by Type(USD Million)
  • Table 135. Human Organoids Brain Organoids , by Region USD Million (2023-2028)
  • Table 136. Human Organoids Kidney Organoids , by Region USD Million (2023-2028)
  • Table 137. Human Organoids Lung Organoids , by Region USD Million (2023-2028)
  • Table 138. Human Organoids Intestine Organoids , by Region USD Million (2023-2028)
  • Table 139. Human Organoids Liver Organoids , by Region USD Million (2023-2028)
  • Table 140. Human Organoids Others , by Region USD Million (2023-2028)
  • Table 141. Human Organoids: by Application(USD Million)
  • Table 142. Human Organoids Study of Infection Biology , by Region USD Million (2023-2028)
  • Table 143. Human Organoids Genetic Engineering , by Region USD Million (2023-2028)
  • Table 144. Human Organoids Pathology , by Region USD Million (2023-2028)
  • Table 145. Human Organoids Drug Designing , by Region USD Million (2023-2028)
  • Table 146. Human Organoids Therapeutic Tools , by Region USD Million (2023-2028)
  • Table 147. Human Organoids Others , by Region USD Million (2023-2028)
  • Table 148. South America Human Organoids, by Country USD Million (2023-2028)
  • Table 149. South America Human Organoids, by Type USD Million (2023-2028)
  • Table 150. South America Human Organoids, by Application USD Million (2023-2028)
  • Table 151. South America Human Organoids, by End User USD Million (2023-2028)
  • Table 152. South America Human Organoids, by Components USD Million (2023-2028)
  • Table 153. Brazil Human Organoids, by Type USD Million (2023-2028)
  • Table 154. Brazil Human Organoids, by Application USD Million (2023-2028)
  • Table 155. Brazil Human Organoids, by End User USD Million (2023-2028)
  • Table 156. Brazil Human Organoids, by Components USD Million (2023-2028)
  • Table 157. Argentina Human Organoids, by Type USD Million (2023-2028)
  • Table 158. Argentina Human Organoids, by Application USD Million (2023-2028)
  • Table 159. Argentina Human Organoids, by End User USD Million (2023-2028)
  • Table 160. Argentina Human Organoids, by Components USD Million (2023-2028)
  • Table 161. Rest of South America Human Organoids, by Type USD Million (2023-2028)
  • Table 162. Rest of South America Human Organoids, by Application USD Million (2023-2028)
  • Table 163. Rest of South America Human Organoids, by End User USD Million (2023-2028)
  • Table 164. Rest of South America Human Organoids, by Components USD Million (2023-2028)
  • Table 165. Asia Pacific Human Organoids, by Country USD Million (2023-2028)
  • Table 166. Asia Pacific Human Organoids, by Type USD Million (2023-2028)
  • Table 167. Asia Pacific Human Organoids, by Application USD Million (2023-2028)
  • Table 168. Asia Pacific Human Organoids, by End User USD Million (2023-2028)
  • Table 169. Asia Pacific Human Organoids, by Components USD Million (2023-2028)
  • Table 170. China Human Organoids, by Type USD Million (2023-2028)
  • Table 171. China Human Organoids, by Application USD Million (2023-2028)
  • Table 172. China Human Organoids, by End User USD Million (2023-2028)
  • Table 173. China Human Organoids, by Components USD Million (2023-2028)
  • Table 174. Japan Human Organoids, by Type USD Million (2023-2028)
  • Table 175. Japan Human Organoids, by Application USD Million (2023-2028)
  • Table 176. Japan Human Organoids, by End User USD Million (2023-2028)
  • Table 177. Japan Human Organoids, by Components USD Million (2023-2028)
  • Table 178. India Human Organoids, by Type USD Million (2023-2028)
  • Table 179. India Human Organoids, by Application USD Million (2023-2028)
  • Table 180. India Human Organoids, by End User USD Million (2023-2028)
  • Table 181. India Human Organoids, by Components USD Million (2023-2028)
  • Table 182. South Korea Human Organoids, by Type USD Million (2023-2028)
  • Table 183. South Korea Human Organoids, by Application USD Million (2023-2028)
  • Table 184. South Korea Human Organoids, by End User USD Million (2023-2028)
  • Table 185. South Korea Human Organoids, by Components USD Million (2023-2028)
  • Table 186. Taiwan Human Organoids, by Type USD Million (2023-2028)
  • Table 187. Taiwan Human Organoids, by Application USD Million (2023-2028)
  • Table 188. Taiwan Human Organoids, by End User USD Million (2023-2028)
  • Table 189. Taiwan Human Organoids, by Components USD Million (2023-2028)
  • Table 190. Australia Human Organoids, by Type USD Million (2023-2028)
  • Table 191. Australia Human Organoids, by Application USD Million (2023-2028)
  • Table 192. Australia Human Organoids, by End User USD Million (2023-2028)
  • Table 193. Australia Human Organoids, by Components USD Million (2023-2028)
  • Table 194. Rest of Asia-Pacific Human Organoids, by Type USD Million (2023-2028)
  • Table 195. Rest of Asia-Pacific Human Organoids, by Application USD Million (2023-2028)
  • Table 196. Rest of Asia-Pacific Human Organoids, by End User USD Million (2023-2028)
  • Table 197. Rest of Asia-Pacific Human Organoids, by Components USD Million (2023-2028)
  • Table 198. Europe Human Organoids, by Country USD Million (2023-2028)
  • Table 199. Europe Human Organoids, by Type USD Million (2023-2028)
  • Table 200. Europe Human Organoids, by Application USD Million (2023-2028)
  • Table 201. Europe Human Organoids, by End User USD Million (2023-2028)
  • Table 202. Europe Human Organoids, by Components USD Million (2023-2028)
  • Table 203. Germany Human Organoids, by Type USD Million (2023-2028)
  • Table 204. Germany Human Organoids, by Application USD Million (2023-2028)
  • Table 205. Germany Human Organoids, by End User USD Million (2023-2028)
  • Table 206. Germany Human Organoids, by Components USD Million (2023-2028)
  • Table 207. France Human Organoids, by Type USD Million (2023-2028)
  • Table 208. France Human Organoids, by Application USD Million (2023-2028)
  • Table 209. France Human Organoids, by End User USD Million (2023-2028)
  • Table 210. France Human Organoids, by Components USD Million (2023-2028)
  • Table 211. Italy Human Organoids, by Type USD Million (2023-2028)
  • Table 212. Italy Human Organoids, by Application USD Million (2023-2028)
  • Table 213. Italy Human Organoids, by End User USD Million (2023-2028)
  • Table 214. Italy Human Organoids, by Components USD Million (2023-2028)
  • Table 215. United Kingdom Human Organoids, by Type USD Million (2023-2028)
  • Table 216. United Kingdom Human Organoids, by Application USD Million (2023-2028)
  • Table 217. United Kingdom Human Organoids, by End User USD Million (2023-2028)
  • Table 218. United Kingdom Human Organoids, by Components USD Million (2023-2028)
  • Table 219. Netherlands Human Organoids, by Type USD Million (2023-2028)
  • Table 220. Netherlands Human Organoids, by Application USD Million (2023-2028)
  • Table 221. Netherlands Human Organoids, by End User USD Million (2023-2028)
  • Table 222. Netherlands Human Organoids, by Components USD Million (2023-2028)
  • Table 223. Rest of Europe Human Organoids, by Type USD Million (2023-2028)
  • Table 224. Rest of Europe Human Organoids, by Application USD Million (2023-2028)
  • Table 225. Rest of Europe Human Organoids, by End User USD Million (2023-2028)
  • Table 226. Rest of Europe Human Organoids, by Components USD Million (2023-2028)
  • Table 227. MEA Human Organoids, by Country USD Million (2023-2028)
  • Table 228. MEA Human Organoids, by Type USD Million (2023-2028)
  • Table 229. MEA Human Organoids, by Application USD Million (2023-2028)
  • Table 230. MEA Human Organoids, by End User USD Million (2023-2028)
  • Table 231. MEA Human Organoids, by Components USD Million (2023-2028)
  • Table 232. Middle East Human Organoids, by Type USD Million (2023-2028)
  • Table 233. Middle East Human Organoids, by Application USD Million (2023-2028)
  • Table 234. Middle East Human Organoids, by End User USD Million (2023-2028)
  • Table 235. Middle East Human Organoids, by Components USD Million (2023-2028)
  • Table 236. Africa Human Organoids, by Type USD Million (2023-2028)
  • Table 237. Africa Human Organoids, by Application USD Million (2023-2028)
  • Table 238. Africa Human Organoids, by End User USD Million (2023-2028)
  • Table 239. Africa Human Organoids, by Components USD Million (2023-2028)
  • Table 240. North America Human Organoids, by Country USD Million (2023-2028)
  • Table 241. North America Human Organoids, by Type USD Million (2023-2028)
  • Table 242. North America Human Organoids, by Application USD Million (2023-2028)
  • Table 243. North America Human Organoids, by End User USD Million (2023-2028)
  • Table 244. North America Human Organoids, by Components USD Million (2023-2028)
  • Table 245. United States Human Organoids, by Type USD Million (2023-2028)
  • Table 246. United States Human Organoids, by Application USD Million (2023-2028)
  • Table 247. United States Human Organoids, by End User USD Million (2023-2028)
  • Table 248. United States Human Organoids, by Components USD Million (2023-2028)
  • Table 249. Canada Human Organoids, by Type USD Million (2023-2028)
  • Table 250. Canada Human Organoids, by Application USD Million (2023-2028)
  • Table 251. Canada Human Organoids, by End User USD Million (2023-2028)
  • Table 252. Canada Human Organoids, by Components USD Million (2023-2028)
  • Table 253. Mexico Human Organoids, by Type USD Million (2023-2028)
  • Table 254. Mexico Human Organoids, by Application USD Million (2023-2028)
  • Table 255. Mexico Human Organoids, by End User USD Million (2023-2028)
  • Table 256. Mexico Human Organoids, by Components USD Million (2023-2028)
  • Table 257. Research Programs/Design for This Report
  • Table 258. Key Data Information from Secondary Sources
  • Table 259. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Human Organoids: by Type USD Million (2017-2022)
  • Figure 5. Global Human Organoids: by Application USD Million (2017-2022)
  • Figure 6. South America Human Organoids Share (%), by Country
  • Figure 7. Asia Pacific Human Organoids Share (%), by Country
  • Figure 8. Europe Human Organoids Share (%), by Country
  • Figure 9. MEA Human Organoids Share (%), by Country
  • Figure 10. North America Human Organoids Share (%), by Country
  • Figure 11. Global Human Organoids share by Players 2022 (%)
  • Figure 12. Global Human Organoids share by Players (Top 3) 2022(%)
  • Figure 13. Global Human Organoids share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Sigma-Aldrich, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Sigma-Aldrich, Inc. (United States) Revenue: by Geography 2022
  • Figure 17. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 19. TEMCELL Technologies Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 20. TEMCELL Technologies Inc. (Canada) Revenue: by Geography 2022
  • Figure 21. Organovo (United States) Revenue, Net Income and Gross profit
  • Figure 22. Organovo (United States) Revenue: by Geography 2022
  • Figure 23. BioIVT (United States) Revenue, Net Income and Gross profit
  • Figure 24. BioIVT (United States) Revenue: by Geography 2022
  • Figure 25. 3D Biomatrix, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. 3D Biomatrix, Inc. (United States) Revenue: by Geography 2022
  • Figure 27. Biopredic International (France) Revenue, Net Income and Gross profit
  • Figure 28. Biopredic International (France) Revenue: by Geography 2022
  • Figure 29. Kaly-Cell (France) Revenue, Net Income and Gross profit
  • Figure 30. Kaly-Cell (France) Revenue: by Geography 2022
  • Figure 31. InSphero AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. InSphero AG (Switzerland) Revenue: by Geography 2022
  • Figure 33. 3D Biotek LLC (United States) Revenue, Net Income and Gross profit
  • Figure 34. 3D Biotek LLC (United States) Revenue: by Geography 2022
  • Figure 35. Global Human Organoids: by Type USD Million (2023-2028)
  • Figure 36. Global Human Organoids: by Application USD Million (2023-2028)
  • Figure 37. South America Human Organoids Share (%), by Country
  • Figure 38. Asia Pacific Human Organoids Share (%), by Country
  • Figure 39. Europe Human Organoids Share (%), by Country
  • Figure 40. MEA Human Organoids Share (%), by Country
  • Figure 41. North America Human Organoids Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sigma-Aldrich, Inc. (United States)
  • Thermo Fisher Scientific (United States)
  • TEMCELL Technologies Inc. (Canada)
  • Organovo (United States)
  • BioIVT (United States)
  • 3D Biomatrix, Inc. (United States)
  • Biopredic International (France)
  • Kaly-Cell (France)
  • InSphero AG (Switzerland)
  • 3D Biotek LLC (United States)
Additional players considered in the study are as follows:
Cyfuse Biomedical (Japan) , Promethera Biosciences (Belgium) , Pandorum Technologies (India)
Select User Access Type

Key Highlights of Report


May 2023 205 Pages 71 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Human Organoids Market Quantitative research analysis
Global Human Organoids Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Sigma-Aldrich, Inc. (United States), Thermo Fisher Scientific (United States), TEMCELL Technologies Inc. (Canada), Organovo (United States), BioIVT (United States), 3D Biomatrix, Inc. (United States), Biopredic International (France), Kaly-Cell (France), InSphero AG (Switzerland) and 3D Biotek LLC (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Neural Organoid or Brain Organoid are Widely Produced and Studied" is seen as one of major influencing trends for Human Organoids Market during projected period 2022-2028.
The Human Organoids market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Human Organoids Market Report?

Have a Query? Click Here

Other Related Reports

Human Milk Glycans Comprehensive Study by Application (Hospitals, Clinics, Pharmacies), Components (Macro-micro Nutrients, Water, Human Milk), Forms (Liquid, Powder) Players and Region - Global Marke...
$ 3500
Paraneoplastic Pemphigus Comprehensive Study by Therapy (High Dose Corticosteroids, Steroid Sparing Agents, Others), Medication (Prednisone, Azathioprine, Ciclosporin, Cyclophosphamide, Others), Tumo...
$ 3650
Antibody Validation Comprehensive Study by Type (Standard Antibody Validation, Enhanced Antibody Validation), Antibodies (IgG, IgM, IgA, IgD, IgE), Assays (Western blot (WB), Immunohistochemistry (IH...
$ 3450
RNase Control Comprehensive Study by Type (Positive Control, No Template Control), Application (Research Institutes, Laboratories, Health Institutes, Others), Function (RNA Cloning, CDNA Synthesis, E...
$ 3650
Globular Protein Comprehensive Study by Type (Recombinant Globular Protein, Bovine Globular Protein, Human Globular Protein), Application (Therapeutics, Vaccine, Other), End Use (Hospitals, Clinics) ...
$ 3500
Yeast Twohybrid System Comprehensive Study by Type (Protein-Protein Interaction, Protein-DNA Interaction), Application (Therapeutic, Industrial, Research), Form (Liquid, Tablet), Distribution Channel...
$ 3650